A detailed history of Ritholtz Wealth Management transactions in Innoviva, Inc. stock. As of the latest transaction made, Ritholtz Wealth Management holds 71,657 shares of INVA stock, worth $1.36 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
71,657
Previous 58,425 22.65%
Holding current value
$1.36 Million
Previous $958,000 44.26%
% of portfolio
0.04%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$16.33 - $20.04 $216,078 - $265,169
13,232 Added 22.65%
71,657 $1.38 Million
Q2 2024

Jul 31, 2024

BUY
$14.4 - $16.4 $341,539 - $388,975
23,718 Added 68.34%
58,425 $958,000
Q1 2024

Apr 24, 2024

BUY
$14.56 - $16.78 $312,108 - $359,696
21,436 Added 161.53%
34,707 $528,000
Q4 2023

Jan 18, 2024

BUY
$12.32 - $16.27 $163,498 - $215,919
13,271 New
13,271 $212,000
Q4 2022

Jan 18, 2023

SELL
$11.8 - $13.78 $199,691 - $233,198
-16,923 Reduced 43.66%
21,839 $0
Q3 2022

Oct 18, 2022

SELL
$11.61 - $15.22 $108,832 - $142,672
-9,374 Reduced 19.47%
38,762 $450,000
Q2 2022

Jul 15, 2022

SELL
$14.32 - $19.88 $97,705 - $135,641
-6,823 Reduced 12.41%
48,136 $710,000
Q1 2022

Apr 14, 2022

BUY
$15.39 - $20.25 $293,856 - $386,653
19,094 Added 53.24%
54,959 $1.06 Million
Q4 2021

Jan 18, 2022

BUY
$15.91 - $18.72 $337,196 - $396,751
21,194 Added 144.46%
35,865 $619,000
Q3 2021

Oct 14, 2021

BUY
$13.06 - $17.24 $55,831 - $73,701
4,275 Added 41.12%
14,671 $245,000
Q2 2021

Jul 20, 2021

SELL
$11.45 - $13.96 $5,083 - $6,198
-444 Reduced 4.1%
10,396 $139,000
Q1 2021

May 12, 2021

SELL
$11.06 - $12.87 $49,792 - $57,940
-4,502 Reduced 29.34%
10,840 $130,000
Q4 2020

Jan 19, 2021

BUY
$9.33 - $12.48 $3,125 - $4,180
335 Added 2.23%
15,342 $190,000
Q3 2020

Oct 23, 2020

BUY
$10.33 - $14.49 $43,117 - $60,481
4,174 Added 38.53%
15,007 $157,000
Q2 2020

Jul 15, 2020

BUY
$11.49 - $15.26 $124,471 - $165,311
10,833 New
10,833 $151,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.32B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Ritholtz Wealth Management Portfolio

Follow Ritholtz Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ritholtz Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Ritholtz Wealth Management with notifications on news.